Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Piribedil is an antiparkinsonian agent and piperazine derivative which acts as a D2 and D3 receptor agonist. It also has α2-adrenergic antagonist properties.
The analysis highlights Applications, Medical uses and Side effects as prominent areas in the source structure around Piribedil.
Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.
Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
The extracted context around Piribedil shows recurring relationship patterns in the source. For example, Piribedil → At, CTZ, Tablets Another extracted example is Piribedil → EU: Rx-only, In general: ℞ (Prescription only). Use these groups to spot repeated connection types before inspecting the individual relationships.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
receptor citation needed effect antagonist d2 agonist d3 also medical side pathological elderly attention memory dizziness drug normal piperazine derivative
TTTA extracted 28 structured relationships around Piribedil. Examples in this analysis include Piribedil → 3D model (JSmol) → Interactive image and Piribedil → AHFS/Drugs.com → International Drug Names. The table shows each extracted connection, where it came from and its confidence.
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Piribedil | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Piribedil | AHFS/Drugs.com | International Drug Names | 1.00 | infobox |
| Piribedil | ATC code | N04BC08 (WHO) | 1.00 | infobox |
| Piribedil | Bioavailability | 10% (peak at 1 hour) [citation needed] | 1.00 | infobox |
| Piribedil | CAS Number | 3605-01-4 Y | 1.00 | infobox |
| Piribedil | ChEMBL | ChEMBL1371770 N | 1.00 | infobox |
| Piribedil | ChemSpider | 4684 N | 1.00 | infobox |
| Piribedil | CompTox Dashboard (EPA) | DTXSID9045188 | 1.00 | infobox |
| Piribedil | ECHA InfoCard | 100.020.695 | 1.00 | infobox |
| Piribedil | Elimination half-life | 1.7–6.9 hours [citation needed] | 1.00 | infobox |
| Piribedil | Excretion | Kidney (68%) and bile duct (25%) [citation needed] | 1.00 | infobox |
| Piribedil | Formula | C16H18N4O2 | 1.00 | infobox |
| Piribedil | IUPHAR/BPS | 49 | 1.00 | infobox |
| Piribedil | KEGG | D07305 Y | 1.00 | infobox |
| Piribedil | Legal status | EU: Rx-only | 1.00 | infobox |
| Piribedil | Legal status | In general: ℞ (Prescription only) | 1.00 | infobox |
| Piribedil | Metabolism | extensive liver [citation needed] | 1.00 | infobox |
| Piribedil | Molar mass | 298.346 g·mol−1 | 1.00 | infobox |
| Piribedil | Protein binding | 70–80% [citation needed] | 1.00 | infobox |
| Piribedil | PubChem CID | 4850 | 1.00 | infobox |
| Piribedil | Routes of administration | By mouth | 1.00 | infobox |
| Piribedil | Trade names | Pronoran, Trivastal Retard, Trastal, Trivastan, Clarium, others | 1.00 | infobox |
| Piribedil | UNII | DO22K1PRDJ | 1.00 | infobox |
| Piribedil | is a | antiparkinsonian agent and piperazine derivative which acts as a D2 and D3 receptor agonist | 0.90 | text |
The concept neighborhoods around Piribedil bring nearby vocabulary together. In this analysis, examples include Agonist, Medical and Side. Use the clusters to find adjacent concepts and terminology that may deserve separate research.
For Piribedil, one of the stronger structural bridges in this analysis connects Piribedil with Medical uses. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.
TTTA analyzes the structure around Piribedil to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as Applications, Medical uses & Side effects, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.
Source: Wikipedia — Piribedil · EN edition · Analysis: TopicsToTalkAbout